Product Information
GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0524 per EA under NDC 43547039650. Its NADAC has been published 474 times since May 31, 2017.
Strength
4 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547039650
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077370On Market Since
1/30/2017
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 474 times since May 31, 2017, and over the history we have for it it has declined 50.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0524 per EA |
|---|---|
| All-time high | $0.1215 (Jul 12, 2017) |
| All-time low | $0.0274 (May 22, 2024) |
| 52-week high | $0.0524 |
| 52-week low | $0.0375 |
| Median price | $0.0505 |
| Average price | $0.0556 |
| Largest weekly change | +73.8% (Jun 19, 2024) |
| Weeks tracked | 474 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0524 per EA (NDC 43547039650), effective Jun 24, 2026.
How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 50.1%. It has been tracked across 474 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?
Since May 31, 2017, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.1215 (Jul 12, 2017), with a median of $0.0505 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GLIMEPIRIDE 4 MG TABLET, but none are currently priced below it.
Who manufactures GLIMEPIRIDE 4 MG TABLET?
GLIMEPIRIDE 4 MG TABLET (NDC 43547039650) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification